Brain Health in the Time of COVID-19
Overview
- Phase
- Not Applicable
- Sponsor
- Miro Health
- Enrollment
- 10,000
- Locations
- 1
- Primary Endpoint
- Test the hypothesis that COVID-19 infection will lead to increased risk of neurological impairment
Overview
Brief Summary
This is a nationwide research program to study the neurological effects of COVID-19. It is open to the public. Healthy individuals and individuals who are or have been infected with COVID-19 are encouraged to join the effort. The study can be done at home with internet access and an iPad or iPhone. Participation takes about one hour.
To learn more, go to https://www.mirohealth.com/consent/
Detailed Description
Neurological complications have been reported in patients with COVID-19. To better understand neurological complications, a group of research hospitals are collaborating to track neurological outcomes. We know that COVID-19 can invade our nervous system, but little is known about the range of effects that COVID-19 might have on the brain. This study aims to gain real-time information about the neurological health of the U.S. population to advance knowledge of COVID-19.
At the conclusion of the study, you will receive non-medical information on your brain function as well as study findings and publications made possible by your participation. With your permission, Miro Health can also release the results of your assessment to your physician. In order for Miro Health to do this, you will be required to confirm your identity online, sign a HIPAA agreement to share the information with your physician, and to enter your physician's name, email, and contact information. Study duration will depend on the development of the COVID-19 pandemic.
To participate, you must submit a valid email. No other personally identifiable information will be gathered at this time.
To participate, you will:
Answer online questions Answer a few questions about your health Download the Miro Health app from the iTunes store Open the app and complete Miro's interactive tasks (30 mins)
Advisory: Should you feel that you have symptoms related to COVID-19, contact your healthcare provider or local community health office. Miro Health cannot provide healthcare assistance.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Other
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •18 years of age or older
- •Access to an iPad bought in 2013 or later
- •Access to stable Wi-Fi
- •Access to iTunes
- •Exclusion Criteria for healthy:
- •Below age 18
- •Preexisting neurological, psychiatric, or developmental disorder
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Test the hypothesis that COVID-19 infection will lead to increased risk of neurological impairment
Time Frame: ~1 year
Each participant's Risk Score of mild cognitive impairment will be calculated using machine learning methods on a percent range of 0-100%. Miro Mobile Assessments will measure each individual's functional performance in neurocognitive, neurobehavioral, motor, and emotional domains. Miro Mobile is a clinically-validated iPad application in use by Johns Hopkins and other research centers. Miro Questionnaires will gather each individual's demographic data. To learn more, go to https://www.mirohealth.com/consent/ Miro Functional Assessments evaluate: Attention Executive function Learning and Memory Motor function Processing speed Speech and language Visuospatial function
Determine cognitive and behavioral functional patterns that predict susceptibility to neurological impairment due to COVID-19
Time Frame: ~1 year
Miro Questionnaires will gather each individual's demographic and medical history data. Miro Mobile Assessments will measure each individual's CNS functional performance. From this data, Miro will test the hypothesis that health indicators exist that can predict the likelihood of a COVID-19 infection leading to neurological impairment. Miro Functional Assessments evaluate: Attention Executive function Learning and Memory Motor function Processing speed Speech and language Visuospatial function
Secondary Outcomes
No secondary outcomes reported